Ken Griffin’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $135M | Sell |
4,741,501
-1,449,685
| -23% | -$38.6M | 0.02% | 795 |
|
|
2026
Q2 | $149M | Sell |
6,191,186
-1,168,679
| -16% | -$30.6M | 0.02% | 714 |
|
|
2026
Q1 | $207M | Buy |
7,359,865
+1,952,489
| +36% | +$52M | 0.03% | 443 |
|
|
2025
Q4 | $135M | Sell |
5,407,376
-4,879,551
| -47% | -$123M | 0.02% | 687 |
|
|
2025
Q3 | $262M | Sell |
10,286,927
-4,579,276
| -31% | -$113M | 0.04% | 372 |
|
|
2025
Q2 | $360M | Buy |
14,866,203
+7,831,434
| +111% | +$183M | 0.06% | 226 |
|
|
2025
Q1 | $178M | Sell |
7,034,769
-7,838,540
| -53% | -$205M | 0.03% | 410 |
|
|
2024
Q4 | $395M | Buy |
14,873,309
+6,811,116
| +84% | +$185M | 0.07% | 199 |
|
|
2024
Q3 | $233M | Sell |
8,062,193
-12,333,440
| -60% | -$360M | 0.05% | 312 |
|
|
2024
Q2 | $571M | Buy |
20,395,633
+7,886,096
| +63% | +$217M | 0.12% | 108 |
|
|
2024
Q1 | $347M | Buy |
12,509,537
+879,463
| +8% | +$24.4M | 0.07% | 209 |
|
|
2023
Q4 | $335M | Buy |
11,630,074
+9,343,112
| +409% | +$282M | 0.07% | 192 |
|
|
2023
Q3 | $75.9M | Buy |
2,286,962
+162,461
| +8% | +$5.75M | 0.02% | 783 |
|
|
2023
Q2 | $77.9M | Buy |
2,124,501
+600,673
| +39% | +$23.4M | 0.02% | 767 |
|
|
2023
Q1 | $62.2M | Buy |
1,523,828
+330,884
| +28% | +$14.3M | 0.01% | 912 |
|
|
2022
Q4 | $61.1M | Sell |
1,192,944
-2,858,017
| -71% | -$137M | 0.01% | 971 |
|
|
2022
Q3 | $177M | Buy |
4,050,961
+3,121,361
| +336% | +$152M | 0.04% | 354 |
|
|
2022
Q2 | $48.7M | Sell |
929,600
-499,168
| -35% | -$25.4M | 0.01% | 1035 |
|
|
2022
Q1 | $74M | Buy |
1,428,768
+447,036
| +46% | +$23.2M | 0.02% | 828 |
|
|
2021
Q4 | $58M | Sell |
981,732
-4,336,153
| -82% | -$215M | 0.01% | 1054 |
|
|
2021
Q3 | $229M | Buy |
5,317,885
+4,608,491
| +650% | +$204M | 0.05% | 300 |
|
|
2021
Q2 | $27.8M | Sell |
709,394
-7,448,658
| -91% | -$290M | 0.01% | 1700 |
|
|
2021
Q1 | $296M | Buy |
8,158,052
+2,246,608
| +38% | +$79.8M | 0.07% | 179 |
|
|
2020
Q4 | $218M | Buy |
5,911,444
+4,734,237
| +402% | +$174M | 0.06% | 236 |
|
|
2020
Q3 | $43.2M | Buy |
1,177,207
+3,685
| +0.3% | +$136K | 0.01% | 966 |
|
|
2020
Q2 | $38.4M | Sell |
1,173,522
-6,997,192
| -86% | -$251M | 0.01% | 974 |
|
|
2020
Q1 | $267M | Buy |
8,170,714
+5,281,685
| +183% | +$190M | 0.12% | 87 |
|
|
2019
Q4 | $113M | Buy |
2,889,029
+1,170,510
| +68% | +$43.9M | 0.05% | 343 |
|
|
2019
Q3 | $61.7M | Buy |
1,718,519
+1,142,162
| +198% | +$43.8M | 0.03% | 636 |
|
|
2019
Q2 | $25M | Sell |
576,357
-331,215
| -36% | -$13.9M | 0.01% | 1218 |
|
|
2019
Q1 | $38.5M | Buy |
907,572
+323,435
| +55% | +$13.7M | 0.02% | 849 |
|
|
2018
Q4 | $25.5M | Sell |
584,137
-3,753,611
| -87% | -$164M | 0.01% | 1048 |
|
|
2018
Q3 | $191M | Buy |
4,337,748
+4,283,216
| +7,855% | +$174M | 0.09% | 183 |
|
|
2018
Q2 | $1.98M | Sell |
54,532
-66,929
| -55% | -$2.41M | ﹤0.01% | 4131 |
|
|
2018
Q1 | $4.31M | Sell |
121,461
-78,165
| -39% | -$2.83M | ﹤0.01% | 2629 |
|
|
2017
Q4 | $7.23M | Sell |
199,626
-6,725,828
| -97% | -$242M | ﹤0.01% | 2051 |
|
|
2017
Q3 | $247M | Buy |
6,925,454
+5,699,813
| +465% | +$193M | 0.19% | 63 |
|
|
2017
Q2 | $41.2M | Buy |
1,225,641
+966,495
| +373% | +$32.1M | 0.03% | 590 |
|
|
2017
Q1 | $8.86M | Buy |
259,146
+19,441
| +8% | +$646K | 0.01% | 1529 |
|
|
2016
Q4 | $7.79M | Buy |
239,705
+228,616
| +2,062% | +$7.36M | 0.01% | 1578 |
|
|
2016
Q3 | $376K | Sell |
11,089
-992,156
| -99% | -$35M | ﹤0.01% | 5304 |
|
|
2016
Q2 | $35.3M | Sell |
1,003,245
-404,549
| -29% | -$13.6M | 0.04% | 489 |
|
|
2016
Q1 | $41.7M | Sell |
1,407,794
-2,716,427
| -66% | -$81.8M | 0.05% | 367 |
|
|
2015
Q4 | $133M | Buy |
4,124,221
+3,335,351
| +423% | +$111M | 0.15% | 132 |
|
|
2015
Q3 | $24.8M | Sell |
788,870
-1,580,632
| -67% | -$53.4M | 0.02% | 757 |
|
|
2015
Q2 | $79.4M | Sell |
2,369,502
-1,230,449
| -34% | -$42.3M | 0.07% | 309 |
|
|
2015
Q1 | $125M | Buy |
3,599,951
+1,412,747
| +65% | +$47.3M | 0.12% | 171 |
|
|
2014
Q4 | $68.1M | Sell |
2,187,204
-4,469,480
| -67% | -$135M | 0.07% | 326 |
|
|
2014
Q3 | $197M | Buy |
6,656,684
+3,416,255
| +105% | +$101M | 0.21% | 71 |
|
|
2014
Q2 | $96.2M | Sell |
3,240,429
-663,011
| -17% | -$19.9M | 0.11% | 178 |
|
|
2014
Q1 | $125M | Sell |
3,903,440
-2,902,856
| -43% | -$91.2M | 0.15% | 116 |
|
|
2013
Q4 | $208M | Buy |
6,806,296
+6,716,344
| +7,467% | +$206M | 0.27% | 47 |
|
|
2013
Q3 | $2.58M | Sell |
89,952
-8,559,786
| -99% | -$245M | ﹤0.01% | 2167 |
|
|
2013
Q2 | $242M | Hold |
8,649,738
| – | – | 0.42% | 20 |
|
Other funds holding PFE
Ken Griffin's PFE Position: Q3 2026 in Review
Ken Griffin reduced its Pfizer (PFE) stake by 23% in Q3 2026, selling an estimated $38.6M and leaving 4,741,501 shares worth $135M. The position accounts for 0.02% of the portfolio, ranked #795.
Ken Griffin first reported a position in PFE in Q2 2013 and has held it in 54 quarters since. The position peaked at $571M in Q2 2024. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Ken Griffin held 4,741,501 shares of Pfizer worth $135M as of Q3 2026.
- Ken Griffin sold 1,449,685 Pfizer shares in Q3 2026, an estimated $38.6M.
- Pfizer made up 0.02% of Ken Griffin's portfolio in Q3 2026, its #795 holding.
- Ken Griffin first reported a position in Pfizer in Q2 2013 and has held it in 54 quarters since.
- Ken Griffin's Pfizer position peaked at $571M in Q2 2024.
- 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.